Wed, January 11, 2012
Tue, January 10, 2012
Mon, January 9, 2012
Sun, January 8, 2012
Sat, January 7, 2012
Fri, January 6, 2012
Thu, January 5, 2012
Wed, January 4, 2012
Tue, January 3, 2012
Mon, January 2, 2012
Sat, December 31, 2011
Fri, December 30, 2011
Thu, December 29, 2011
Wed, December 28, 2011
Tue, December 27, 2011
Mon, December 26, 2011
Fri, December 23, 2011

PDL BioPharma to Present at the 30th Annual JP Morgan Healthcare Conference


//health-fitness.news-articles.net/content/2012/ .. 30th-annual-jp-morgan-healthcare-conference.html
Published in Health and Fitness on Thursday, January 5th 2012 at 4:10 GMT by Market Wire   Print publication without navigation


PDL BioPharma to Present at the 30th Annual JP Morgan Healthcare... -- INCLINE VILLAGE, Nev., Jan. 5, 2012 /PRNewswire/ --

PDL BioPharma to Present at the 30th Annual JP Morgan Healthcare Conference

[ ]

 

 

INCLINE VILLAGE, Nev., Jan. 5, 2012 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: [ PDLI ]) today announced that John P. McLaughlin, the company's president and chief executive officer, is scheduled to present at the 30th Annual JP Morgan Healthcare Conference in San Francisco on Thursday, January 12, 2012 at 9:30 a.m. Pacific time.

(Logo: [ http://photos.prnewswire.com/prnh/20110822/SF55808LOGO ])

This presentation will be available to interested parties through a live and archived audio webcast. To access the live and subsequently archived webcast of the presentation, go to the Company's website at [ http://www.pdl.com ] and go to "Company Presentations & Events." Please connect to the website at least 15 minutes prior to the call to allow for any software download that may be necessary. The archived webcast will be available for seven days following each presentation.

About PDL BioPharma

PDL pioneered the humanization of monoclonal antibodies and, by doing so, enabled the discovery of a new generation of targeted treatments for cancer and immunologic diseases. Today, PDL is focused on intellectual property asset management, investing in new royalty bearing assets and maximizing the value of its patent portfolio and related assets. For more information, please visit [ www.pdl.com ].

NOTE: PDL BioPharma and the PDL BioPharma logo are considered trademarks of PDL BioPharma, Inc.

SOURCE PDL BioPharma, Inc.

[ Back to top ]

RELATED LINKS
[ http://www.pdl.com ]


Publication Contributing Sources